<DOC>
	<DOC>NCT01125436</DOC>
	<brief_summary>The purpose of this study is to determine if vitamin D will improve physical performance in older adults with heart failure.</brief_summary>
	<brief_title>A Trial of Vitamin D Therapy in Patients With Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>NYHA class IIIV Able to walk Serum 25OHD level 37.5 ng/ml or less Fully titrated on heart failure medications Osteoporosis Primary hyperparathyroidism or hypercalcemia. Nephrolithiasis Hemo or peritoneal dialysis and/or creatinine of &gt; 2.5 Current use of daily vitamin D greater than 400 IU, corticosteroids,PTH, androgen or estrogen Current illicit drug user or &gt; 3 alcoholic drinks a day Metastatic or advanced cancer Myocardial infarction in the preceding 6 months Medications which can lower vitamin D levels or bioavailability</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>